There was also no significant difference in the rate of patients with pre-diagnosed and pre-treated type 2-diabetes, intake of anti-hyperlipidemic drugs and also not for adjusted fasting glucose, HbA1c, total cholesterol, HDL, LDL, ALAT, ASAT, AP, GGT fasting triglyceride levels or IGF-1. This evidence concerns the gene IGF1 and type 2 diabetes mellitus.